| Patents for C12R 1 - Micro-organisms (92,025) |
|---|
| 05/20/1992 | EP0485611A1 Method of preparing plasmid having capabilities of expressing and processing after translation of retrovirus gene, plasmid obtained thereby and product of expression thereof |
| 05/20/1992 | EP0485569A1 Cholesterol esterases with variable substrate specificity |
| 05/20/1992 | EP0485525A1 Monoclonal antibody to acetylated lysine residues in recombinant bovine somatotropin. |
| 05/20/1992 | EP0485504A1 Cell culture methods for producing activated protein c. |
| 05/20/1992 | EP0485497A1 Il-2 deletion mutants |
| 05/20/1992 | EP0485476A1 Atherosclerotic plaque specific antigens, antibodies thereto, and uses thereof |
| 05/20/1992 | EP0485430A1 Methods and compositions for ameliorating the symptoms of sepsis |
| 05/20/1992 | EP0485407A1 Proteins with tnf activity |
| 05/20/1992 | EP0477285A4 Processes for the recovery of microbially produced chymosin |
| 05/20/1992 | EP0477284A4 Processes for the recovery of naturally produced chymosin |
| 05/20/1992 | EP0465572A4 Genetic engineering of novel plant phenotypes |
| 05/20/1992 | EP0258404B1 Method of detecting antibody against htlv-iii |
| 05/20/1992 | EP0248057B1 Glucose tolerance factor and method of making same |
| 05/20/1992 | EP0229110B1 Solubilization and oxidation of somatotropin from transformed microorganisms |
| 05/20/1992 | EP0131627B1 Specific cea-family antigens, antibodies specific thereto and their methods of use |
| 05/20/1992 | CA2032091A1 Microbial reduction of benzazepine and benzothiazepine derivatives |
| 05/19/1992 | US5114967 Antibiotic alisamycin and its use |
| 05/19/1992 | US5114930 Anthelmintics |
| 05/19/1992 | US5114922 Animal extracts from leeches |
| 05/19/1992 | US5114853 Generic engineering |
| 05/19/1992 | US5114852 Chimeric fused monooxygenase of cytochrome P-450 and NADPH-cytochrome P-450 reductase |
| 05/19/1992 | US5114850 Methods for preparing acetate esters of diols and polyols using corynebacterium oxydans in substantially aqueous media |
| 05/19/1992 | US5114849 Protectants for microbial fermentation |
| 05/19/1992 | US5114848 Prepared from bifidobacterium; immunomodulating properties |
| 05/19/1992 | US5114847 Fusion with cytoplasm from transformed cells; hybridomas |
| 05/19/1992 | US5114846 Culture of streptomyces and selecting the asprogenous colonies |
| 05/19/1992 | US5114842 Immunology, DNA and DNA sequences encoding genes |
| 05/19/1992 | US5114711 Covalently linked polypeptide cell modulators such as interferon-lymphotoxin conjugates |
| 05/19/1992 | CA1301168C Process for producing macrolide compounds |
| 05/19/1992 | CA1301101C Method and device for the carrying out of a microbiological or enzymatic process |
| 05/19/1992 | CA1301100C Resolution of racemates of 3-acyloxy- bicyclo-[3.3.0]-octane-7-one-2-carboxylic acid esters by stereo-specific enzymatic or microbiological acylate hydrolysis |
| 05/19/1992 | CA1301098C Purified enzyme and process therefor |
| 05/19/1992 | CA1301095C Human che type proteins and their production |
| 05/19/1992 | CA1301094C Bacillus thuringiensis crystal protein gene toxin segment |
| 05/19/1992 | CA1301060C Bacterial treatment to preserve hay quality by addition of microorganisms of the genus bacillus |
| 05/14/1992 | WO1992008135A1 A diagnostic assay for lyme disease |
| 05/14/1992 | WO1992008131A1 Development of dna probes and immunological reagents of human tumor associated antigens |
| 05/14/1992 | WO1992007950A1 Method of gene transfer using retrotransposons |
| 05/14/1992 | WO1992007943A1 Retroviral vectors useful for gene therapy |
| 05/14/1992 | WO1992007942A1 Polypeptides involved in the expression of resistance to glycopeptidic antibiotics |
| 05/14/1992 | WO1992007941A1 Assembled viral particles and their use in a vaccine to rotaviral disease |
| 05/14/1992 | WO1992007938A1 Cell growth inhibitors |
| 05/14/1992 | WO1992007937A1 Polypeptides having human dopaminergic receptor activity, nucleic acids coding for said polypeptides and uses thereof for screening active substances on said polypeptides |
| 05/14/1992 | WO1992007573A1 Genetic modification of endothelial cells |
| 05/14/1992 | WO1992007572A1 Agents and methods for binding to elam-1 |
| 05/14/1992 | WO1991018984A3 New antifungal preparations, process for making such preparations, process for obtaining plants with decreased susceptibility to fungi |
| 05/14/1992 | CA2095256A1 Retroviral vectors useful for gene therapy |
| 05/14/1992 | CA2094916A1 Assembled viral particles and their use in a vaccine to rotaviral disease |
| 05/14/1992 | CA2094911A1 Agents and methods for binding to elam-1 |
| 05/14/1992 | CA2094378A1 Development of dna probes and immunological reagents of human tumor associated antigens |
| 05/14/1992 | CA2072581A1 Method of gene transfer using retrotransposons |
| 05/14/1992 | CA2055425A1 Polypeptide, dna fragment encoding the same and process for producing the same, and enzyme inhibition process, drug composition and methods of treating using the same |
| 05/13/1992 | EP0485091A1 Process for the production of analogues of immunomycin |
| 05/13/1992 | EP0484908A2 Microbiological process for the preparation of hydroxylated Pyrazinederivatives |
| 05/13/1992 | EP0484863A1 A monoclonal antibody and a method for measuring malondialdehyde-reacted low-density-lipoproteins |
| 05/13/1992 | EP0484856A2 Dynemicin C antitumor antibiotic |
| 05/13/1992 | EP0484500A1 Recombinant protein which binds to a complex viral antigen of hiv-1 |
| 05/13/1992 | EP0484452A1 Fibulin |
| 05/13/1992 | EP0484440A1 Efficient directional genetic cloning system |
| 05/13/1992 | EP0484380A1 Uses of interleukin-4 and method for purifying it |
| 05/13/1992 | EP0448650A4 Herpes simplex virus type i expression vector |
| 05/12/1992 | US5112951 Separation of anti-metal chelate antibodies |
| 05/12/1992 | US5112950 Factor viii analog, preparation process, and pharmaceutical composition containing it |
| 05/12/1992 | US5112945 Preparation of islet amyloid polypeptides (iapp) and antibodies to iapp |
| 05/12/1992 | US5112944 Antitumor agents |
| 05/12/1992 | US5112858 Antitumor agent |
| 05/12/1992 | US5112806 Antibiotic, mersacidin, a process for the preparation thereof and the use thereof as a pharmaceutical |
| 05/12/1992 | US5112757 Method for obtaining human hepatocyte cultures |
| 05/12/1992 | US5112754 Tissue plasminogen-activating factor and nonoclonal antibody |
| 05/12/1992 | US5112753 Method of identification and preparation of probes for pestiviruses, oligonucleotides and probes thus obtained and a method of detection of pestiviruses |
| 05/12/1992 | US5112749 Recombinant DNA sequences for attenuated bacterium, Salmonella or Shigella and epitopes |
| 05/12/1992 | US5112748 Hybrid cells producing an antigen characteristic of the hepatitis b virus obtained from hepatocytes and established monkey cells, a process for obtaining these hybrid cells and their application to the production of the aforesaid antigen |
| 05/12/1992 | US5112747 Culturing escherichia or serratia, biosynthesis |
| 05/12/1992 | US5112746 Fermentation of streptomyces |
| 05/12/1992 | CA1300617C Mono- and diepoxide derivatives of 23-deoxy-ll-f28249 compounds |
| 05/12/1992 | CA1300536C Process for antifungal fermentation product and culture |
| 05/12/1992 | CA1300533C Sterol regulatory elements |
| 05/12/1992 | CA1300512C Personal care products containing bioemulsifiers |
| 05/10/1992 | WO1992008495A1 Cytokine immunoconjugates |
| 05/09/1992 | CA2055125A1 Microbiological process for the production of hydroxylated pyrazine derivatives |
| 05/08/1992 | CA2055145A1 Dna encoding a protein which binds to the enhancer of .alpha.-fetoprotein gene |
| 05/07/1992 | WO1992007579A1 Soluble mannose receptor peptides |
| 05/07/1992 | CA2095729A1 Soluble mannose receptor peptides |
| 05/07/1992 | CA2054791A1 Method for altering post-translational processing of tissue plasminogen activator |
| 05/06/1992 | WO1992007580A1 Therapeutic uses of melanin |
| 05/06/1992 | EP0484281A2 Cyclosporins |
| 05/06/1992 | EP0484240A2 Process for preparing hydrogen gas using microorganism |
| 05/06/1992 | EP0484017A2 Endothelin precursors, genes and receptors |
| 05/06/1992 | EP0483961A1 Specific binding agents |
| 05/06/1992 | EP0483797A1 Method for cloning and producing the Nco I restriction endonuclease |
| 05/06/1992 | EP0483691A2 Xyloseisomerase gene of thermus aquaticus, xyloseisomerase and process for preparation of fructose |
| 05/06/1992 | EP0483597A2 Process of preparation of carebastin |
| 05/06/1992 | EP0483351A1 Soluble single chain t cell receptors |
| 05/06/1992 | EP0483281A1 Recombinant human thyroid peroxidase |
| 05/06/1992 | EP0483249A1 Method of transcriptionally modulating gene expression and of discovering chemicals capable of functioning as gene expression modulators |
| 05/06/1992 | EP0483247A1 Recombinantly produced human membrane cofactor protein (mcp) |
| 05/06/1992 | EP0461180A4 Development of a monoclonal antibody based detection system for listeria monocytogenes |
| 05/06/1992 | CN1060872A Spheroplast fusions of phaffia rhodozyma cells |
| 05/06/1992 | CA2054659A1 Dynemicin c antitumour antibiotic |
| 05/05/1992 | US5110943 Certain phenoxy (or 5-trifluoromethyl-pyridyl-oxy)-phenoxy-2-yl-propane derivatives |